6 research outputs found
Cryptococcal virulence in humans : learning from translational studies with clinical isolates
Cryptococcosis, an invasive mycosis caused by Cryptococcus spp, kills between 20% and 70% of the patients who develop it. There are no vaccines for prevention, and treatment is based on a limited number of antifungals. Studying fungal virulence and how the host responds to infection could lead to new therapies, improving outcomes for patients. The biggest challenge, however, is that experimental cryptococcosis models do not completely recapitulate human disease, while human experiments are limited due to ethical reasons. To overcome this challenge, one of the approaches used by researchers and clinicians is to: 1) collect cryptococcal clinical isolates and associated patient data; 2) study the set of isolates in the laboratory (virulence and host-pathogen interaction variables, molecular markers); 3) correlate the laboratory and patient data to understand the roles fungal attributes play in the human disease. Here we review studies that have shed light on the cryptococcosis pathophysiology using these approaches, with a special focus on human disease. Isolates that more effectively evade macrophage responses, that secrete more laccase, melanize faster and have larger capsules in the cerebrospinal fluid are associated with poorer patient outcomes. Additionally, molecular studies have also shown that cryptococcal clades vary in virulence, with clinical impact. Limitations of those studies include the use of a small number of isolates or retrospectively collected clinical data. The fact that they resulted in very important information is a reflection of the impact this strategy has in understanding cryptococcosis and calls for international collaboration that could boost our knowledge
Evaluation elements forming Z-DNA as potential regulators of the expression of biopharmaceuticals in CH0-K1 cells
Dissertação (mestrado)âUniversidade de BrasĂlia, Programa de PĂłs-graduação em Patologia Molecular, 2013.Introdução: o grupo de Imunologia Molecular/UnB jĂĄ produziu anticorpos recombinantes e humanizados de interesse comercial como o anti-CD18, anti-CD3, ou acadĂȘmico como o anti-Z22,assim como fatores plasmĂĄticos humanos. Os vetores de expressĂŁo utilizados contĂȘm o promotor de CMV-IA. O objetivo desse trabalho foi explorar regiĂ”es formadoras de Z-DNA, e testar diretamente o papel do anticorpo estabilizador de Z-DNA (antiZ22NLS - Z22) no efeito transcricional do promotor CMV modificado (zCMV-IA). Material e MĂ©todos: O primeiro passo foi reconstruir o cassete de expressĂŁo dos vetores tradicionais utilizados nesse trabalho, pCO e pCO?600. Para isso, fusionamos o gene GFP ao anticorpo recombinante aCD3. Os passos seguintes foram a introdução de sequĂȘncias formadoras de Z-DNA (Z1, Z3 e Z4) e controles nĂŁo formadores de Z-DNA (Z2 e Z5) a montante do promotor CMV-IA. Resultados e DiscussĂŁo: foram construĂdos 10 vetores de expressĂŁo: 5 construçÔes pCO (pZ1, pZ2, pZ3, pZ4 e pZ5) e 5 construçÔes pCO?600 (?Z1, ?Z2, ?Z3, ?Z4 e ?Z5); transfecção de cĂ©lulas CHO-K1 com as construçÔes utilizando Lipofectamina LTX na proporção 1:1 de DNA e reagente LTX; Por fim co-transfecção de cĂ©lulas com cada vetor de expressĂŁo e vetor pMacZ22NLS e como controle de cada vetor de expressĂŁo tambĂ©m foi feita transfecção com vetor pMac vazio. Em comparação aos controles em todas as construçÔes a presença do pMacZ22 NLS aumentou a eficiĂȘncia de transfecção. AtravĂ©s de citometria de fluxo se verificou aumento da MFI no gate das cĂ©lulas GFP+ em atĂ© 25 % quando foi co-transfectado vetor com anti-Z-DNA. ConclusĂŁo: foi mostrado o papel de anti Z22 como indutor e estabilizador de Z-DNA e seu efeito facilitador da transcrição. _______________________________________________________________________________________ ABSTRACTIntroduction: Recombinant antibodies are now a reality in therapeutics. But its production is still a challenging issue. We have been developing expression vectors for heterologous expression of recombinant antibodies based on the CMV promotor. We had previously shown that a Z-DNA forming region upstream the promotor/enhancer enhances luciferase expression in a repĂłrter vector. The aim of this study was to explore Z-DNA forming regions, and directly test the role of a Z-DNA stabilizing antibody on a modified CMV promoter (zCMV). Material and Methods: Initially, the GFP gene was fused with a recombinant antibody anti-CD3 and the fusion cassette was introduced in both pCO and pCO?6OO. Then we introduced the Z-DNA forming sequences (Z1, Z3 and Z4) and control sequences (Z2 and Z5) upstream of the CMV promoter. CHO cells were transfected using Lipofectamine LTX 1:1, DNA and LTX reagent. To provide the trans acting anti-Z-DNA antibody, we cotransfect cells with the vector pMACZ22NLS, that produces a scFv of the anti-Z-DNA mAb Z22 fused to a nuclear localization signal (Intrabody). Flow cytometry was use to follow GFP expression. Results and Discussion: 10 expression vectors were constructed: 5 pCO constructs (pZ1, pZ2, pZ3, pZ4 and pZ5) and 5 pCO?600 constructs (AZ1, AZ2, AZ3, AZ4 and AZ5); The constructions with Z-DNA forming sequences showed an improvement of expression of the reporter gene when compared to the control sequences. Moreover the co-transfection with the anti-Z-DNA vector enhances the MFI of gated GFP+ cells by 25%. Conclusion: The Z-DNA forming sequences improve heterologous gene expression and the presence of anti-Z-DNA in trans was shown to enhance the Z-DNA effect probably due to a stabilization effect
Laccase affects the rate of Cryptococcus neoformans nonlytic exocytosis from macrophages
Nonlytic exocytosis is a process in which previously ingested microbes are expelled from host phagocytes with the concomitant survival of both cell types. This process has been observed in the interaction of Cryptococcus spp. and other fungal cells with phagocytes as distant as mammalian, bird, and fish macrophages and ameboid predators. Despite a great amount of research dedicated to unraveling this process, there are still many questions about its regulation and its final benefits for host or fungal cells. During a study to characterize the virulence attributes of Brazilian clinical isolates of C. neoformans, we observed great variability in their rates of nonlytic exocytosis and noted a correlation between this process and fungal melanin production/laccase activity. Flow cytometry experiments using melanized cells, nonmelanized cells, and lac1Î mutants revealed that laccase has a role in the process of nonlytic exocytosis that seems to be independent of melanin production. These results identify a role for laccase in virulence, independent of its role in pigment production, that represents a new variable in the regulation of nonlytic exocytosis
Faster cryptococcus melanization increases virulence in experimental and human cryptococcosis
Cryptococcus spp. are human pathogens that cause 181,000 deaths per year. In this work, we systematically investigated the virulence attributes of Cryptococcus spp. clinical isolates and correlated them with patient data to better understand cryptococcosis. We collected 66 C. neoformans and 19 C. gattii clinical isolates and analyzed multiple virulence phenotypes and hostâpathogen interaction outcomes. C. neoformans isolates tended to melanize faster and more intensely and produce thinner capsules in comparison with C. gattii. We also observed correlations that match previous studies, such as that between secreted laccase and disease outcome in patients. We measured Cryptococcus colony melanization kinetics, which followed a sigmoidal curve for most isolates, and showed that faster melanization correlated positively with LC3-associated phagocytosis evasion,
virulence in Galleria mellonella and worse prognosis in humans. These results suggest that the speed of melanization, more than the total amount of melanin Cryptococcus spp. produces, is crucial for virulence
Faster Cryptococcus Melanization Increases Virulence in Experimental and Human Cryptococcosis
Cryptococcus spp. are human pathogens that cause 181,000 deaths per year. In this work, we systematically investigated the virulence attributes of Cryptococcus spp. clinical isolates and correlated them with patient data to better understand cryptococcosis. We collected 66 C. neoformans and 19 C. gattii clinical isolates and analyzed multiple virulence phenotypes and host–pathogen interaction outcomes. C. neoformans isolates tended to melanize faster and more intensely and produce thinner capsules in comparison with C. gattii. We also observed correlations that match previous studies, such as that between secreted laccase and disease outcome in patients. We measured Cryptococcus colony melanization kinetics, which followed a sigmoidal curve for most isolates, and showed that faster melanization correlated positively with LC3-associated phagocytosis evasion, virulence in Galleria mellonella and worse prognosis in humans. These results suggest that the speed of melanization, more than the total amount of melanin Cryptococcus spp. produces, is crucial for virulence